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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞsponse could not be 
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x ǲǳǲǳǤ 
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the 
population that are covered under the screening or 
health care programme. 
x ǲǳǲǳǤ 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ? response could not be 
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
WHO  ? Word Health Organisation  
PPP  ? Purchasing Power Parity 
GDP  ? Gross Domestic Product 
NICU - Neonatal-intensive care unit 
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3 Population and Healthcare Overview 
The population of Italy is 60,551,416 (World Bank, 2018a) and a birth rate estimated at 7.8 
births/1,000 population in 2016 (World Bank, 2018b). The change in population and birth 
rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Italy has a reported population density of 206 people per square kilometre in 2017 and this 
has risen from 172 people per square kilometre in 1961 (World Bank, 2018c). In terms of 
healthcare facilities, the total density of hospitals in 2013 was 2.08 per 100,000 population 
(WHO, 2016a). Infant mortality in 2017 is estimated at 2.9 deaths/1,000 live births in total 
(World Bank, 2018d). 
The average life expectancy in Italy is estimated at 82.5 (World Bank, 2018e), with a death 
rate 10.1 deaths/1,000 population in 2016 (World Bank, 2018f). Italy has a gross national 
income per capita (PPP int. $, 2013) of $34,000 (WHO, 2016b). The estimated total 
expenditure on health per capita in 2014) was $3,239 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 9.2% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in Italy between 1960 and 2017 
 
Source: Information sourced from World Bank (2018)  
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4 Vision Screening Commissioning and Guidance 
In Italy, vision screening is organised nationally with regional variations between protocols 
and is embedded into a general preventative child healthcare screening system. Vision 
screening is funded by national health insurance, with funding allocation determined by local 
governments. 
The content of the vision screening programme is decided upon by public health organisations 
and local government. It is not known when the vision screening programme was first 
implemented. The vision screening programme has been changed since its start date, 
specifically, it has been extended through to other regions of the country. Vision screening is 
funded based on economic availability; there are no guidelines for funding. In matters of 
health, there is a certain level of autonomy between the various regions. There are no vision 
screening guidelines in Italy. It is not known how often the vision screening programme is 
reviewed, who decides upon any revisions, or how often reviews are funded and take place. 
There are methods for quality assessment imposed by the government  ? however, it is not 
clear how this is conducted.  
Vision screening is conducted by ophthalmologists, paediatricians, or orthoptists in either a 
hospital, school, or external clinics. There is no available data regarding the number of vision 
screening professionals per million population. Nurses have been identified as general 
professionals who do not screen, but could do so with additional training. However, there is 
currently no specific training to perform vision screening. 
There has been no cost-effectiveness analysis of the vision screening programme, or any 
other studies on the effectiveness of the vision screening programme.   
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5 Screening programme  
The target conditions of vision screening are retinopathy of prematurity, congenital eye 
disorders and amblyopia. Children are screened at birth, 1 month and 6 years of age. Every 
child is invited for vision screening; this is done by the paediatricians. The health care 
professionals delivering vision screening, venue for screening and tests used vary depending 
on the age of the child as shown in Tables 1, 2 and 3 respectively. Specific details of the 
screening offered within each age group are described more fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies aged up to 3 months are screened by a paediatrician or ophthalmologist in a 
hospital. The vision screening tests used include red reflex testing and a retinal examination 
and this is conducted within the first month of life.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies aged up to 3 months are screened by a paediatrician, ophthalmologist, 
or orthoptist. The vision screening is conducted in a hospital using an eye inspection, red 
reflex testing and ocular motility assessment. These tests are conducted within the first 
month of life. The orthoptist will carry out the examination of the eye and the first part of the 
eye examination (Ocular motility). Only the paediatrician or ophthalmologist perform fundus 
red reflex examination to diagnose a white pupil. Referral criteria for further diagnostic 
examination are undefined, but it is known that vision screening is repeated, before referral 
for further diagnostic examination if there is the presence of abnormal red reflex.  
5.3 Vision screening - 3 months to 36 months 
Children aged 3 months to 36 months are screened by a paediatrician within the 
ƉĂĞĚŝĂƚƌŝĐŝĂŶ ?Ɛ office. The tests conducted include eye inspection, red reflex testing, ocular 
motility assessment and a retinal examination. These tests are conducted between 12-18 
months of life. Referral for further examination to an ophthalmologist by the paediatrician 
occurs after one inconclusive test and vision screening is repeated, before referral for further 
diagnostic examination if there is the presence of abnormal red reflex.   
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months to 7 years are screened twice by a paediatrician, orthoptist, or 
ophthalmologist in a hospital or school. The tests conducted include eye inspection, red reflex 
testing, retinal examination, cover test, alternating cover test, stereopsis using the Lang test 
and visual acuity measurement. Visual acuity is measured for the first time at 3 years of age 
in a hospital or external clinic and this is repeated for a second time at 6 years of age in 
schools. Visual acuity is measured by either an ophthalmologist (Tumbling E test), 
paediatrician (optotype with animal figures), or orthoptist. Vision screening is repeated, 
before referral for further diagnostic examination if there is the presence of abnormal red 
reflex. It is not known how many inconclusive tests necessitate referral. 
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 Paediatrician Ophthalmologist Orthoptist 
Preterm babies  
 
9 9 × 
0 to 3 months  9 9 9 
3 to 36 months  9 × × 
3 to 7 years  9 9 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
Eye 
inspection 
Red reflex 
testing 
Eye 
motility 
Retinal 
examination 
Cover test Alternating 
cover test 
Visual acuity 
measurement 
Stereopsis 
Preterm babies  
× 9 × 9 × × × × 
0 to 3 months  9 9 9 × × × × × 
3 to 36 months  9 9 9 9 × × × × 
3 to 7 years  9 9 × 9 9 9 9 9 
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Table 3: Location of vision screening for each age group  
Table 3 
Hospital Paediatrician office School 
Preterm babies  9 × × 
0 to 3 months  9 × × 
3 to 36 months  × 9 × 
3 to 7 years  9 × 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error in infants from 6 months of age. It provides objective results and 
is used to detect amblyopic risk factors. This differs from other methods used to screen 
children for amblyopia which focus on detection of the actual condition and the resulting 
visual loss. No automated vision screening is conducted in Italy.  
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7 Provision for Visually Impaired  
It is not known exactly how many schools there are for blind or severely visually impaired 
children. This provision is variable across different regions in Italy. The costs per child for the 
schools for blind or severely visually impaired children are not known. There is also no 
information available concerning the special support for visually impaired children who 
attend regular primary school.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
There are no sources for precise data on the prevalence of amblyopia or strabismus in the 
Italian pediatric population. The prevalence of treated or untreated amblyopia is estimated 
at 2%, with a prevalence of persistent amblyopia of 1% by the age of 7 years. There is no 
information to provide estimates for the incidence of the four types of amblyopia (strabismic, 
refractive, combined mechanism and deprivation). The prevalence of strabismus is estimated 
at 2%. 
8.2 Coverage 
The percentage of eligible children invited or attending vision screening before the age of 7 
years is unknown. Other treatment options include patching. Not all children are treated due 
to non-attendance to vision screening and/or non-attendance to diagnostic examination with 
the ophthalmologist. Ophthalmologists are the only professionals who prescribe glasses for 
children under the age of 7 years. 
There is no documentation of non-attendance of referral assessment after an abnormal 
screening test result, and therefore, the percentage of compliance with a referral after an 
abnormal screening test results is unknown.  
8.3 Screening evaluation 
The percentage of false negatives and false positives from vision screening is not known. The 
positive predictive value of a refer results after vision screening, the sensitivity of vision 
screening, and the specificity of vision screening are all unknown.  
It is reported that, in Italy, the variation between regions does not permit accurate collection 
of data. Therefore, there is no standard protocol concerning monitoring and/or reporting on 
the outcomes of the vision screening programmes.  
8.4 Treatment success 
The percentage of children treated for congenital eye disorders is not known. It is estimated 
that the 70% of children who are screened before the age of 7 years, and identified as having 
strabismus, receive treatment. It is estimated that the 70% of children who are screened 
before the age of 7 years, and identified as having amblyopia, receive treatment. 
The percentage of patients treated for congenital cataract surgery, amblyopia and 
strabismus per year by either an orthoptist or ophthalmologists is estimated at 2% of the 
population 
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The salary costs, per year, for each vision screening professional is not known. The salary costs 
per hour for each vision screening professional has not been determined. It is not known how 
much it costs to train general preventative child healthcare screening professionals, from 
leaving secondary education to qualification. The total screening costs per year for vision 
screening is not available, neither are the total costs per child, per year, for vision screening 
nationally. Vision screening is free of charge to parents and there is no financial reward for 
parents when children attend their vision screening appointment. There is also no penalty for 
not attending and vision screening is not obligatory. 
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients, with refractive amblyopia and 
strabismic amblyopia are not known. The number of months of treatment and follow-up 
required depends on the severity of amblyopia, compliance with treatment. This period may 
vary from 6 months to 5 years, depending on the duration of occlusive treatment. 
9.3 Cost of Treatment for strabismus  
 The estimated costs strabismus surgery, including follow-up are $600 (528.18 Euros*) per 
year.  
9.4 Cost of treatment for cataract 
The estimated costs for congenital cataract surgery, including follow-up of deprivation 
amblyopia, are $1500 (1,320.45 Euros*) per year.  
 
 
 
 
 
 
 
 
 
 
*Currency conversion as of 29/11/2018  
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